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1. Predictors of cardio pulmonary resuscitation
outcome in post-operative cardiac children
B. Nasser
PSCCQ, Buridha, Saudi Arabia
Outcome of cardiopulmonary resuscitation (CPR) in
children with congenital heart disease has improved and
many children survived after in hospital cardiac arrestthe
purpose of this study is to determine predictor of poor out-
come after CPR in critical children undergoing cardiac
surgerywe conducted a retrospective chart review and
data analysis of all CPR records and charts of all post-
operative cardiac children who had cardiac arrest and
required resuscitation from 2012 till 2015. Demographic,
pre-operative data were reviewed and analyzed during
study period 18 post-operative pediatric cardiac patients
had CPR. Nine of them had return of spontaneous circula-
tion (ROSC) and survived (50%). On average CPR was
required on the 3rd postoperative day. Univariate analysis
demonstrated that poor outcome was associated with
higher lactic acid measured 4–6 h prior to arrest
(P = 0.045) (P = 0.02) coupled with higher heart rate
(P = 0.031), lower O2 saturation (P = 0.01) and lower core
body temperature (P = 0.019) record 6 h before arrest.
Non-survival required longer resuscitation duration and
more epinephrine doses (P < 0.05) higher heart rate, lower
core body temperature , lower O2 saturation and higher
lactic acid measured 6 h before arrest are possible predic-
tors of poorer outcome and mortality following CPR in
post-operative cardiac children.
http://dx.doi:10.1016/j.jsha.2016.04.002
2. Minimally invasive mitral valve surgery why do
you take the risks?
A. Attia a, F. Oueida b, K. Alkhamees b
K. Eskander b, M. Alrefaei c, H. Ammar b
a Saud Al-Babtain Cardiac Centre, Dammam, Saudi
Arabia; b Saud Al-Babtain Cardiac Centre, Cardiac
Surgery, Dammam, Saudi Arabia; c Saud Al-Babtain
Cardiac Centre, Cardiology, Dammam, Saudi Arabia
During recent years, minimally invasivemitral valve sur-
gery (MIMVS) become the preferredmethod of mitral valve
repair and replacement inmany institutionsworldwidewith
excellent results, in spite of there isnocleardifinitionofmini-
mally invasive surgery and we do not have efficient studies
about the risks of MIMVS comparing to conventional mitral
valve surgery. Many studies are needed to clarify the need
for either conventional or minimally invasive mitral valve
surgery instead of personal preference. The patient’s demo-
graphic profile, intraoperative data and postoperative out-
comes of patients undergoing minimally invasive mitral
valve surgery were retrospectively collected from our data-
base from May 2011 to April 2014. We will present early
and mid-term outcomes of patients undergoing minimally
invasivemitral valve surgery in our institution. Seventy con-
secutive patients (45 male and 25 female), age 35 ± 12 years,
underwent MIMVS surgery. Mean preoperative New York
Heart Association function class was 2.6 ± 0.7.Mean ejection
fraction was 50 ± 8. Cardiopulmonary bypass was instituted
through femoral cannulation (28 of 70, 40%), or direct aortic
cannulation (42 of 70, 25%). Aortic cross-clamp used in (66
of 70, 94.2%). Without aortic cross-clamp in (4 of 70, 5.7%),
mitral valve repair has been done in (52 of 70, 74.2%), mitral
valve replacement (18 of 70, 25.7%). Concomitant procedures
included AF ablation (24 of 70, 34.2%), and tricuspid valve
repair (33of 70, 47.1%).Nomortality recorded, residualmitral
regurge was found in (6 of 70, 8.5%) during 1 year follow up.
Cardiopulmonary bypass, and ‘‘skin to skin’’ surgery were
95 ± 35 and 250 ± 74 min, respectively. 4 patients (5.7%)
underwent reexploration for bleeding and (57 of 70, 81.4%)
did not receive any blood transfusions. Six patients (8.5%)
sustained face oedema. Mean length of hospital stay was
7 ± 3.8 days. 18 patients (25.7%) did not feel any interest
regarding cosmotic advantage over conventional surgery.
Minimally invasivemitral valve surgery is an excellent alter-
native to conventional mitral valve surgery in most cases
however comparing to conventional mitral surgery it shows
long bypass time, long cross clamp time, difficult reexplora-
tion for bleeding and multiple body incisions.
http://dx.doi:10.1016/j.jsha.2016.04.003
3. Early outcomes of minimally invasive versus
conventional mitral valve surgery in mitral valve
diseases. A single institutional experience
E. Nourelden a, W. Abu Khudair b, M. Alnajjar c,
A. Arnous b
aKing Fahd Armed Force Hospital, Jeddah, Saudi
Arabia;
bKing Fahd Armed Force Hospital, Cardiac Surgery,
Jeddah, Saudi Arabia; cKing Fahd Armed Force Hospi-
tal, CCU, Jeddah, Saudi Arabia
Minimally invasive techniques in cardiac surgery
gained popularity due to many advantages like less post-
operative pain, minimal blood loss, less hospital stay, less
cost. Minimally invasive mitral valve surgery through
A
BSTR
A
C
TS
186 SHA27 INDEX FOR THE ABSTRACTS J Saudi Heart Assoc
2016;28:185–220
right anterolateral mini thoracotomy became safe
technique. In our study we compared mini-MV surgery
with conventional technique regarding cross clamp time,
bypass time, total blood loss, reopening for bleeding, and
hospital and ICU length of stay. In our institution
between 2010 and 2015, 147 patients underwent mini-
mally invasive mitral surgery through right lateral mini-
thoracotomy 8 cm incision and 118 patient underwent
conventional mitral valve surgery through median ster-
notomy in minimally invasive technique: mean age was
38 ± 20 vs 59 ± 21, 70.7% were female (n = 104) vs 39.8%
(n = 47), 23.8% were associated with tricuspid valve
regurgitation (n = 33) vs 55% in conventional technique
(n = 65), 0.08% were able to use endovascular clamp
(n = 12), mean Euroscore predected risk of mortality
14.7 ± 13.6% vs 8.7 ± 10.9%. Minimally invasive mitral
valve repair surgery was accomplished in 77.5%
(n = 114) vs 46.15% (n = 55 ) and replacement of mitral
valve in 22.4% (n = 30) vs 53.8% (n = 64 ), concomitant
procedures consists of tricuspid valve surgery in 23.8%
(n = 35) vs 55% (n = 65), primary mitral valve repair
included implantation of rigid annuloplasty ring in
79.6% vs 38.9% (n = 46), duration of cardiopulmonary
bypass in minimally invasive surgery was 123 ± 64 min
vs 116 ± 62 min, cross clamp time was 64 ± 27 min vs
59 ± 23 min, postoperative mechanical ventilation time
4 ± 1.5 h vs 6.5 ± 2 h, ICU lenght of stay (LOS) was
48 ± 12 h vs 3 ± 1 days. Minimally invasive mitral surgery
can be performed very safely with excellent early results.
mini-MV surgery can be performed with a reasonable
operative time, good perioperative course with decrease
in postoperative ICU and hospital LOS.
http://dx.doi:10.1016/j.jsha.2016.04.004
4. Suture-less bio-prosthetic aortic valve replace-
ment: Early clinical and hemodynamic outcome
A. Arifi a, H. Najm b, M. Ahmad b, A. Khan b
aKAMC-Ministry of National Guard Health Affairs,
Riyadh, Saudi Arabia; bKAMC-Ministry of National
Guard Health Affairs, Cardiac Surgery-Cardiac
Sciences, Riyadh, Saudi Arabia
Suture-less bio-prostheses (SBP) are a recent addition
in the surgical armamentarium in the surgical treatment
of sever aortic valve disease that offer rapid deployment,
shorter bypass & ischemic times and excellent hemody-
namic performance even in small aortic annulus. We pre-
sent our initial experience and short-term clinical and
hemodynamic results with the use of suture-less
bio-prostheses. Between May 2011 and August 2015, 61
patients, with mean age of 72.6 years and severe aortic
stenosis underwent aortic valve replacement with a
SBP. 28 were males and 19 were females. Mean euro-
SCORE was 11.5. 55% had coronary artery disease, 8.5%
had severe mitral regurgitation and 6.4% had severe tri-
cuspid regurgitation. Left ventricular dysfunction was
present in 28% patients and 83% had elevated right ven-
tricular systolic pressure. Average size of aortic annulus
was 21.7 mm. 42.5% patients underwent isolated aortic
valve replacement while 57.5% had concomitant proce-
dures including coronary artery bypass grafting (25
patients). Average cross clamp time in isolated aortic
valve replacement was 34 min and total bypass time
was 46 min. Mean gradient across the prostheses was
an average of 8.9 mmHg intra-operatively with 4.3% pre-
valence of mild para-prosthetic leak and 10.6% preva-
lence of mild prosthetic regurgitation. In-hospital
mortality was 2.1% (1 patient). At follow-up, average
mean trans-aortic gradients were 15 mmHg and preva-
lence of mild prosthetic and para-prosthetic leak was
10.5%. Average left ventricular diastolic dimensions
changed from 4.93 mm pre-operatively to 4.42 mm post-
operatively (p = 0.023) and left ventricular systolic
dimensions changed from 3.39 mm pre-operatively to
3.05 mm post-operatively (p = 0.124). Use of suture-less
bio-prosthesis for aortic valve replacement produces
excellent hemodynamic results with low incidence of
para-prosthetic leakage and prosthetic regurgitation.
Persistent low trans-aortic gradients and regression of
left ventricular diastolic dimensions seen on follow up
is likely to offer long-term survival benefit.
http://dx.doi:10.1016/j.jsha.2016.04.005
5. Mitral valve replacement for mitral stenosis: 15
years single center experience
A. Arifi a, A. Al Mosa a, A. Omair b, H. Najm c
aKAMC-Ministry of National Guard Health Affairs,
Riyadh, Saudi Arabia; bKAMC-Ministry of National
Guard Health Affairs, Medical education, Riyadh, Saudi
Arabia; cKAMC-Ministry of National Guard Health
Affairs, Cardiac Surgery-Cardiac Sciences, Riyadh,
Saudi Arabia
Mitral valve replacement (MVR) with either a biopros-
thetic or a mechanical valve is the treatment of choice for
severe mitral stenosis. This study aimed to evaluate and
compare the early and late outcome of mitral valve repla-
cement (mechanical versus bioprosthetic) for severe
mitral stenosis. A retrospective cohort study was per-
formed on prospectively collected data involving mitral
stenosis patients who have undergone MVR with either
bioprosthetic (BMV) (n = 50) or mechanical (MMV)
(n = 145) valves in our institute from 1999 to 2012. Data
were analyzed for early and late mortality, NYHA func-
tional classes, stroke, early and late valve-related compli-
cations, and survival. Chi Square test, logistic regression,
Kaplan Meier curve, and dependent proportions tests
were performed. A total of 195 patients were included
in the study with a follow-up of 190 patients (97.5%).
One patient died early post-operatively; twelve patients
died late in the post-operative period, BMV group (6)
and the MMV (6). The Late mortality had significantly
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